Create a Profile
Get In Touch Mobile
Accel Research Sites featured in CNBC article about Pfizer vaccine effectiveness in children
The CDC has reported positive numbers regarding Pfizer’s pediatric COVID-19 vaccine for children ages 12 to 18 years old.
The CDC found the vaccine is over 93% effective against hospitalization for that age group.
Dr. Salma Elfaki was a part of several pediatric COVID-19 vaccine clinical trials and was featured seeing a patient in a photo in the article.
See it here.
Ready to be part of healthcare history? Find the right clinical trial for you.